Literature DB >> 8433184

Returning to work after a unilateral hand fracture.

M L Kasdan1, L A June.   

Abstract

We complied a case series involving 556 employed patients who sustained unilateral hand fractures requiring open reduction and internal fixation and a modification of their normal work activities and schedules. Time from injury to limited duty averaged 5 days, with 62% of the patients returning to work 1 day after surgery. Time from injury to resuming regular duty averaged 56 days. Both sexes averaged a return to work on limited duty after 5 days, but women returned to regular duty an average 5 days later than men. Patients with workers' compensation injuries, joint fractures, multiple fractures, tendon and/or nerve disruptions, and fractures requiring metal fixation rather than periosteal sutures required longer periods on off-duty and limited-duty statuses.

Entities:  

Mesh:

Year:  1993        PMID: 8433184     DOI: 10.1097/00043764-199302000-00013

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  4 in total

1.  Recovering from traumatic occupational hand injury following surgery: a biopsychosocial perspective.

Authors:  Michelle Louise Roesler; Aleck Ian Glendon; Frances Veronica O'Callaghan
Journal:  J Occup Rehabil       Date:  2013-12

2.  Validity of the dictionary of occupational titles for assessing upper extremity work demands.

Authors:  Lonneke Opsteegh; Remko Soer; Heleen A Reinders-Messelink; Michiel F Reneman; Corry K van der Sluis
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

3.  Determinants of return to work in patients with hand disorders and hand injuries.

Authors:  Lonneke Opsteegh; Heleen A Reinders-Messelink; Donna Schollier; Johan W Groothoff; Klaas Postema; Pieter U Dijkstra; Corry K van der Sluis
Journal:  J Occup Rehabil       Date:  2009-05-13

4.  The socioeconomic impact of orthopaedic trauma: A systematic review and meta-analysis.

Authors:  Nathan N O'Hara; Marckenley Isaac; Gerard P Slobogean; Niek S Klazinga
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.